In the United States, the use and abuse of opioids has become an epidemic, costing the nation billions of dollars every year. While opioids can be a safe and effective method of pain management, they can also be highly addictive. The issue is compounded when physicians and other practitioners prescribe opioids to patients who are at high risk of opioid misuse or abuse without first exploring other options. As a healthcare provider, you play a critical role in addressing the opioid epidemic. In this module, 3 cases will be explored relating to the use of opioid medications, and their impacts on patient outcomes.
Section 1: Introduction A. About This Course B. Learning Objectives Section 2: The Opioid Epidemic A. An Ever-Present Concern B. Review C. Summary Section 3: When Necessary A. Meet Karen! B. Opioid Risk Identification and Stratification C. Activity D. Information Therapy E. Activity F. Pharmacological Management of Pain G. Activity H. Review I. Summary Section 4: Its Going Tibia Okay A. Meet John! B. The Brief Pain Inventory C. Activity D. The D.I.R.E Score E. Activity F. Multimodal Treatment Planning G. Activity H. Review I. Summary Section 5: Building A Case for Pain Control A. Meet Colin B. AUDIT and DAST-10 C. Activity D. Review E. Summary Section 6: Conclusion A. Summary B. Course Contributors C. Resources D. References E. Congratulations! F. Exam G. BrainSparks
Adam Roesner, BSN has been working with various quality measures optimization since 2013. His experience in program management in both clinical and performance measures allows a unique perspective on the challenge faced by healthcare systems today. Adam has presented trainings on HCAHPS programs for sales forces and executive leadership alike, and has managed various skin health and HCAHPS educational programs and bundles for acute, post-acute, and IDN facilities. Disclosure: Adam Roesner, BSN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.Expert Reviewer: Jack M. Gorman, MD
Jack M. Gorman, M.D. co-founded Critica Inc, a non-profit corporation, with his daughter, Dr. Sara Gorman, in 2016 and is its President and Chair. Critica is devoted to fighting science denial and promoting the acceptance of science in health and safety decision-making.
Before founding Critica, Dr. Gorman was Chief Scientific Officer and Senior Vice-President of both Comprehensive NeuroScience Inc and Care Management Technologies Inc. Dr. Gorman is co-editor of the textbooks Treatments that Work, now in its fourth edition, and Comprehensive Textbook of AIDS Psychiatry, now in its second edition, and author of the popular book The Essential Guide to Psychiatric Drugs, which appeared in its fourth edition in 2007. With his daughter, Dr. Sara Gorman, he wrote Denying to the Grave, on the reasons behind denial of scientific medical evidence, published by Oxford University Press in 2016. It has been discussed in media throughout the world. His newest book, Neuroscience at the Intersection of Mind and Brain, was published in 2018.Disclosure: Jack M. Gorman, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.